<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Ireland</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Ireland.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ie.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation During the 2024/25 Season in Northern Ireland, UK</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/</guid>
    <pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that seasonal influenza vaccination provided meaningful protection against hospitalisation in 2024/25, with the largest benefit observed in children, supporting continued vaccination efforts in Northern Ireland.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Avian influenza in Ireland: a spatiotemporal, subtype and host-based analysis (1983–2024)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1099-jgv-0-002218-190bdd1c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1099-jgv-0-002218-190bdd1c/</guid>
    <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
    <description>Understanding these shifting transmission dynamics supports the refinement of regional monitoring protocols and underscores the necessity of integrating wildlife tracking with broader ecological assessments.</description>
    <category>H5N1</category>
    <category>Influenza</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Influenza Vaccine Effectiveness During the 2023/2024 Season: A Test‐Negative Case–Control Study Among Emergency Hospital Admissions With Respiratory Conditions in Northern Ireland</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70149-8eb09af5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70149-8eb09af5/</guid>
    <pubDate>Wed, 10 Sep 2025 00:00:00 GMT</pubDate>
    <description>The data suggest that routine immunization programs help mitigate the volume of severe respiratory cases necessitating acute hospitalization across multiple age demographics.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/</guid>
    <pubDate>Mon, 02 Dec 2024 00:00:00 GMT</pubDate>
    <description>Continued emphasis on seasonal immunization remains critical for safeguarding vulnerable demographics and pediatric cohorts. Public health initiatives should persist in highlighting documented protective outcomes to sustain coverage rates among eligible groups.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Influenza vaccine effectiveness in Ireland during two influenza seasons, 2022/23 and 2023/24</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/</guid>
    <pubDate>Mon, 28 Oct 2024 00:00:00 GMT</pubDate>
    <description>Sustaining routine immunization initiatives appears capable of reducing outpatient utilization for influenza-related illnesses, with notably stronger protective signals observed when administering live attenuated formulations to school-aged youth.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-01-015-363843da/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-01-015-363843da/</guid>
    <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
    <description>Despite existing vaccination programs targeting older adults and high-risk groups, substantial influenza burden persists in Europe. The findings suggest that combined strategies using improved vaccines for the elderly and universal pediatric vaccination may offer direct and indirect protection that is cost-effective across diverse European settings, supporting broader policy considerations for seasonal influenza control.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Spotlight on measles 2010: Measles outbreak in Ireland 2009-2010</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-15-09-19500-en-b9ecafc6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-15-09-19500-en-b9ecafc6/</guid>
    <pubDate>Thu, 04 Mar 2010 00:00:00 GMT</pubDate>
    <description>The report documents measles transmission involving unvaccinated people and subsequent wider population spread in Ireland. These observations provide outbreak context relevant to vaccination coverage and transmission patterns, without establishing causality or broader population effects.</description>
    <category>Measles</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
